Skip to main content
Yijia Li, MD, Infectious Disease, Pittsburgh, PA

YijiaLiMD(He/Him)

Infectious Disease Pittsburgh, PA

HIV/AIDS Medicine

Physician

Dr. Li is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Li's full profile

Already have an account?

  • Office

    3601 Fifth Ave
    Pittsburgh, PA 15213

Summary

  • Infectious Diseases Physician at UPMC

Education & Training

  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2019 - 2021
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 2016 - 2019
  • Peking Union Medical College
    Peking Union Medical CollegeClass of 2015, MD
  • Tsinghua University
    Tsinghua UniversityPre-Medical education, 2007 - 2010

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2022 - 2026
  • MA State Medical License
    MA State Medical License 2019 - 2023
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • Emerging-Generation Awards ASCI, 2024
  • Maxwell Finland Award for Excellence in Research Massachusetts Infectious Diseases Society, 2022
  • Young Investigator Scholarship CROI- International Antiviral Society–USA, 2021
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • High Nasal and Total SARS-CoV-2 RNA Levels Associated with Longer Recovery
    High Nasal and Total SARS-CoV-2 RNA Levels Associated with Longer RecoveryNovember 9th, 2022
  • Mass General Brigham Study Highlights Varied Risk of Persistent COVID-19 Infection Among Immunocompromised Patients
    Mass General Brigham Study Highlights Varied Risk of Persistent COVID-19 Infection Among Immunocompromised PatientsJanuary 25th, 2024
  • Prolonged SARS-CoV-2 Risk Varies Across Immunosuppressive Conditions
    Prolonged SARS-CoV-2 Risk Varies Across Immunosuppressive ConditionsFebruary 3rd, 2024

Professional Memberships

  • IDSA
    Member
  • IAS-USA
    Member

Other Languages

  • Chinese (Mandarin)